Company Filing History:
Years Active: 1997-2005
Title: The Innovations of Robert B Diasio
Introduction
Robert B Diasio is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of gene expression, holding a total of 4 patents. His work focuses on innovative methods that have the potential to impact medical treatments and therapies.
Latest Patents
One of his latest patents is a method of down-regulating gene expression. This patent discloses a method wherein a pharmacological formulation comprising a chimeric oligonucleotide complementary to the gene is orally administered to an animal. The oligonucleotide administered contains at least one phosphorothioate internucleotide linkage and at least one of several chemical linkages, including alkylphosphonate and phosphoramidate, among others. This innovative approach aims to provide a new avenue for gene regulation in therapeutic applications.
Career Highlights
Robert B Diasio is associated with Hybridon, Inc., a company known for its advancements in the field of biotechnology. His work at Hybridon has allowed him to explore and develop groundbreaking methods that contribute to the understanding and manipulation of gene expression.
Collaborations
Some of his notable coworkers include Sudhir Agrawal and Ruiwen Zhang. Their collaborative efforts have likely played a role in the development of innovative solutions in the biotechnology sector.
Conclusion
Robert B Diasio's contributions to gene expression regulation through his patents reflect his commitment to advancing medical science. His work continues to inspire future innovations in biotechnology and therapeutic applications.